Abstract
Thapsigargin is a natural product that specifically inhibits all known SERCA calcium pumps with high affinity. We investigated the effects of thapsigargin on cardiac sarcoplasmic reticulum (SR) by measuring the oxalate-supported calcium uptake rate in the unfractionated homogenate and in the isolated SR fraction. The uptake rate in both the isolated SR and unfractionated homogenate are stimulated about two-fold by preincubation with high concentrations of ryanodine, which closes the SR efflux channel. Thapsigargin stoichiometrically and completely inhibited the calcium uptake rate in the isolated SR, both in the presence and absence of SR channel blockade. In contrast, thapsigargin nearly completely inhibited the homogenate calcium uptake only in the absence of SR channel blockade; in the presence of blockade, about 20% of the uptake activity was insensitive to thapsigargin. This result unmasks a thapsigargin-insensitive, ryanodine-sensitive component of calcium uptake in the heart. This activity is in an oxalate-permeable pool and is inhibited by cyclopiazonic acid, another inhibitor of the SERCA calcium pumps. There was no TG-insensitive activity in the rat EDL muscle homogenate. The absence of thapsigargin-insensitive uptake activity in the isolated SR can be attributed to its inactivation during the isolation of the SR. The oxalate permeability and ryanodine sensitivity suggest that the TG-insensitive calcium uptake activity is closely related to the classical SR. The different thapsigargin sensitivities suggests the existence of two kinds of intracellular calcium pumps in the heart.
Similar content being viewed by others
References
Meissner G: Ryanodine activation and inhibition of the Ca release channel of sarcoplasmic reticulum. J Biol Chem 261: 6300–6306, 1986
Feher JJ, Lipford GB: Mechanism of action of ryanodine on cardiac sarcoplasmic reticulum. Biochim Biophys Acta 813: 77–86, 1985
Lytton J, Westlin M, Hanley MR: Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca‐ATPase family of calcium pumps. J Biol Chem 266: 17067–17071, 1991
Inesi G, Sagara Y: Thapsigargin, a high affinity and global inhibitor of intracellular Ca2+ transport ATPases. Arch Biochem Biophys 298: 313–317, 1992
Goeger DE, Riley RT, Domer JW, Cole RJ: Cyclopiazonic acid inhibition of the Ca2+ ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles. Biochem Pharmacol 37: 978–981, 1988
Stefanova HI, East JM, Lee AG: Covalent and non‐covalent inhibitors of the phosphate transporter of sarcoplasmic reticulum. Biochim Biophys Acta 1064: 321–328, 1991
Feher JJ, Fabiato A: Cardiac sarcoplasmic reticulum: Calcium uptake and release. In: G.A. Langer (ed) Calcium and the Heart. Raven Press Ltd, New York, 1990, pp 199–268
Trumble WR, Sutko JL, Reeves JP: ATP‐dependent calcium transport in cardiac sarcolemmal membrane vesicles. Life Sci 27: 207–214, 1980
Feher JJ, Stephens MJ, Alderson BH, Poland JL: Contribution of the ryanodine‐sensitive fraction to capabilities of cardiac SR. J Mol Cell Cardiol 20: 1107–1118, 1988
Wu Q, Feher JJ: Effect of ischemia and ischemia‐reperfusion on ryanodine binding and Ca2+ uptake of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 27: 1965–1975, 1995
Wrzosek A, Schneider R Grueninger S, Chiesi M: Effect of thapsigargin on cardiac muscle cells. Cell Ca 13: 281–292, 1992
Verma A, Hirsch DJ, Hanley MP, Thastrup O, Christensen SB, Snyder SH: Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain. Biochem Biophys Res Commun 172: 811–816, 1990
Nori A, Fulceri R, Gamberucci A, Benedetti A, Volpe P: Biochemical and functional heterogeneity of rat cerebrum microsomal membranes in relation to SERCA Ca2+‐ATPases and Ca2+ release channels. Cell Ca 19: 375–381, 1996
Feher JJ, Davis MD: Isolation of rat cardiac sarcoplasmic reticulum with improved Ca2+ uptake and ryanodine binding. J Mol Cell Cardiol 23: 249–258, 1991
Feher JJ, Manson NR, Poland JL: The rate and capacity of calcium uptake by sarcoplasmic reticulum in fast, slow and cardiac muscle: Effects of ryanodine and ruthenium red. Arch Biochem Biophys 265: 171–182, 1988
Feher JJ, LeBolt WR, Manson NH: Differential effect of global ischemia on the ryanodine‐sensitive and ryanodine‐insensitive calcium uptake of cardiac sarcoplasmic reticulum. Circ Res 65: 1400–1408, 1989
Penney CL: A simple micro‐assay for inorganic phosphate. Anal Biochem 75: 201–210, 1976
Alderson BR, Feher JJ: The interaction of calcium and ryanodine with cardiac sarcoplasmic reticulum. Biochim Biophys Acta 900: 221–229, 1987
Jones LR, Cala SE: Biochemical evidence for functional heterogeneity of cardiac sarcoplasmic reticulum vesicles. J Biol Chem 256: 11809–11818, 1981
Taffet GE, Tate CA: The MgATPase activity of rat cardiac sarcoplasmic reticulum is a function of the calcium ATPase protein. Arch Biochem Biophys 299: 287–294, 1992
Seidler NW, Jona I, Vegh M, Martonosi A: Cyclopiazonic acid is a specific inhibitor of the Ca2+‐ATPase of sarcoplasmic reticulum. J Biol Chem 264: 17816–17823, 1989
Takahasi S, Kato Y, Adachi M, Agata N, Tanaka H, Shigenobu K: Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum. J Pharmacol Exp Ther 272: 1095–1100, 1995
Agata N, Tanaka H, Shigenobu K: Possible action of cyclopiazonic acid on myocardial sarcoplasmic reticulum: Inotropic effects on neonatal and adult rat heart. Brit J Pharmacol 108: 571–572, 1993
Caspersen C, Treiman M: Thapsigargin discriminates strongly between Ca2+‐ATPase phosphorylated intermediates with different subcellular distributions in bovine adrenal chromaffin cells. FEBS Lett 377: 31–36, 1995
Poulsen JJ, Caspersen C, Mathiasen D, East JM, Tunwell REA, Lai FA, Maeda N, Mikoshiba K, Treiman M: Thapsigargin‐sensitive Ca2+‐ATPases account for Ca2+ uptake to inositol 1,4,5‐trisphosphatesensitive and caffeine‐sensitive Ca2+ stores in adrenal chromaffin cells. Biochem J 307: 749–758, 1995
Zaidi M, Shankar VS, Tunwell R, Adebanjo OA, Mackrill J, Pazianas M, O'Connell D, Simon BJ, Rifkin BR, Venkitaraman AR, et al.: A ryanodine receptor‐like molecule expressed in the osteoclast plasma membrane functions in extracellular Ca2+ sensing. J Clin Invest 96: 1582–1590, 1995
Bian J, Ghosh TK, Wang J, Gill DL: Identification of intracellular calcium pools. Selective modification by thapsigargin. J Biol Chem 266: 8801–8806, 1991
Waldron RT, Short AD, Gill DL: Thapsigargin‐resistant intracellular calcium pumps. J Biol Chem 270: 11955–11961, 1995
Sagara Y, Fernandez‐Belda F, DeMeis L, Inesi G: Characterization of the inhibition of intracellular Ca2+ transport ATPases by thapsigargin. J Biol Chem 267: 12606–12613, 1992
Kirby MS, Sagara Y, Gaa S, Inesi G, Lederer WJ, Rogers TB: Thapsigargin inhibits contraction and Ca2+ transient in cardiac cells by specific inhibition of the sarcoplasmic reticulum Ca2+ pump. J Biol Chem 267: 12545–12551, 1992
Janczewski AM, Lakatta EG: Thapsigargin inhibits Ca2+ uptake, and Ca2+ depletes sarcoplasmic reticulum in intact cardiac myocytes. Am J Physiol 265: H517–H522, 1993
Bassani JWM, Yuan W, Bers DM: Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol 268: C1313–C1329, 1995
Baudet S, Shaoulian R, Bers DM: Effects of thapsigargin and cyclopiazonic acid on twitch force and sarcoplasmic reticulum Ca2+ content of rabbit ventricular muscle. Circ Res 73: 813–819, 1993
Lewartowski B, Wolska BM: The effect of thapsigargin on sarcoplasmic reticulum Ca2+ content and contractions in single myocytes of guinea‐pig heart. J Mol Cell Cardiol 25: 23–29, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feher, J.J., Lee, K.N. & Wu, Q.Y. Ryanodine-sensitive, thapsigargin-insensitive calcium uptake in rat ventricle homogenates. Mol Cell Biochem 189, 9–17 (1998). https://doi.org/10.1023/A:1006800328118
Issue Date:
DOI: https://doi.org/10.1023/A:1006800328118